Oral News and Research

RSS

EHRA EUROPACE - CARDIOSTIM 2017 to showcase holographic cardiac imaging and other innovations

Holographic cardiac imaging and other innovations will be showcased at the EHRA EUROPACE - CARDIOSTIM 2017 in Vienna, Austria.

18 May 2017

FDA-approved drug improves clinical outcomes among patients with rare immunologic disease

Adding the injectable drug mepolizumab to standard treatment for eosinophilic granulomatosis with polyangiitis (EGPA), a rare immunologic disease, significantly improved clinical outcomes among participants in an advanced clinical trial, scientists report.

18 May 2017

Fetal alcohol exposure reduces taste system's responsiveness to bitter flavor and burning sensation

A new study suggests that fetal alcohol exposure reduces the taste system's responsiveness to the bitter flavor and burning sensation of many varieties of alcoholic beverages.

18 May 2017

Research paves way for safer and more effective drugs to treat type 2 diabetes

Research led by the University of Adelaide is paving the way for safer and more effective drugs to treat type 2 diabetes, reducing side effects and the need for insulin injections.

18 May 2017

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.

18 May 2017

Overweight or obesity linked to increased risk for severe periodontitis

Being overweight or obese was linked with an increased likelihood of having poor oral health in a recent study.

17 May 2017

Untargeted vitamin D supplementation provides little clinical benefit to older adults, study finds

An international study of older adults has found that mass, untargeted provision of vitamin D supplements provides little clinical benefit to many when it comes to the common bone disease, osteoporosis. Instead, the study recommends targeting vitamin D supplements at individuals whose levels of this vitamin are markedly reduced.

16 May 2017

WHO and partners respond to upsurge of cholera cases in Yemen

The World Health Organization and partners are responding to an upsurge in cholera transmission in several parts of Yemen that has claimed 51 lives and caused around 2752 suspected cases since 27 April 2017.

15 May 2017

Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation, the most common heart arrhythmia in the world that affects more than 2.7 million American adults.

12 May 2017

FDA approves use of new Flourish device to treat infants born with esophageal atresia

The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.

12 May 2017

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

ImmusanT, Inc., a clinical-stage company developing Nexvax2, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet in HLA-DQ2.5+ patients with celiac disease, today announced the publication of positive data from two Phase 1 clinical trials of Nexvax2 in celiac disease.

12 May 2017

Leti's New Deal project could revolutionize IBD therapies for great benefit of patients in the European Union

Leti, a technology research institute of CEA Tech, today announced a European Union project to develop a nanotherapy targeting the molecules involved in inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis.

12 May 2017

High vitamin D intake could reduce the risk of an early menopause

A new study published in the American Journal of Clinical Nutrition has revealed that women can cut their risk of an early menopause, by having a high vitamin D intake.

From BetterYou Ltd 11 May 2017

New screening model effectively identifies Latino infants at risk for autism

Georgetown University Medical Center autism specialists working with Latino families in Washington, DC, have developed an effective screening program that identifies Latino infants who may be at risk for autism spectrum disorder (ASD), allowing the opportunity for early intervention.

11 May 2017

Regular use of common painkillers increases risk of heart attack, study reports

A study published in the British Medical Journal suggests that when people use commonly prescribed non-steroidal anti-inflammatory drugs (NSAIDs) for treating pain and inflammation, the risk of heart attack increases as early as in the first week of consumption and particularly within the first month of using such medication in high doses.

10 May 2017

Use of postmenopausal hormone therapy may increase risk of hearing loss

Hearing loss afflicts approximately 48 million Americans and the number is expected to increase as the population ages.

10 May 2017

Study: Systemic therapy preserves vision of uveitis patients better than intraocular implant

Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better - and had fewer adverse outcomes - than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute.

9 May 2017

Study finds effective treatment approach for preserving long-term vision in patients with severe uveitis

Researchers comparing leading treatment approaches for patients with severe uveitis have discovered that systemic therapy with oral corticosteroids and immunosuppression can preserve or improve vision in the long term better than regional implant therapy can.

8 May 2017

Steroids offer no additional relief to emergency patients suffering from hives

Despite standard use for the itching associated with urticaria (commonly known as hives), prednisone (a steroid) offered no additional relief to emergency patients suffering from hives than a placebo did, according to a randomized, placebo-controlled, double-blind, parallel-group study published online yesterday in Annals of Emergency Medicine.

4 May 2017

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.

3 May 2017

Oral News and Research

EHRA EUROPACE - CARDIOSTIM 2017 to showcase holographic cardiac imaging and other innovations

FDA-approved drug improves clinical outcomes among patients with rare immunologic disease

Fetal alcohol exposure reduces taste system's responsiveness to bitter flavor and burning sensation

Research paves way for safer and more effective drugs to treat type 2 diabetes

FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations

Overweight or obesity linked to increased risk for severe periodontitis

Untargeted vitamin D supplementation provides little clinical benefit to older adults, study finds

WHO and partners respond to upsurge of cholera cases in Yemen

Delayed anticoagulation treatment for atrial fibrillation patients increases dementia risk, study finds

FDA approves use of new Flourish device to treat infants born with esophageal atresia

Phase 1 clinical studies reveal safety, tolerability of therapeutic vaccine in celiac disease patients

Leti's New Deal project could revolutionize IBD therapies for great benefit of patients in the European Union

High vitamin D intake could reduce the risk of an early menopause

New screening model effectively identifies Latino infants at risk for autism

Regular use of common painkillers increases risk of heart attack, study reports

Use of postmenopausal hormone therapy may increase risk of hearing loss

Study: Systemic therapy preserves vision of uveitis patients better than intraocular implant

Study finds effective treatment approach for preserving long-term vision in patients with severe uveitis

Steroids offer no additional relief to emergency patients suffering from hives

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News